CBAT Financials Tuesday, July 15, 2014 06:47:53 AM
Post# of 18
Cortronix Biomedical Advancement Technologies, Inc.
Period Ending Aug 31, 2013 Aug 31, 2012 Aug 31, 2011 Aug 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development - - 31 -
Sales, General and Admin. 364 11 16 22
Non-Recurring Items - - 100 -
Other 1 - - -
Operating Income (365) (11) (147) (22)
Income From Continuing Operations
Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax (365) (11) (147) (22)
Interest Expense 75 - 5 -
Earnings Before Tax (439) (11) (152) (22)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (439) (11) (152) (22)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (439) (11) (152) (22)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (439) (11) (152) (22)